Es gab 50 kürzliche Insider-Transaktionen für Delcath Systems, Inc. (DCTH), darunter 43 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.87B und die gesamten Insider-Verkäufe auf $443.45K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Pennell Sandra, Michel Gerard J, Vukovic Vojo. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — DCTH
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-06 |
Pennell Sandra |
Chief Financial Officer |
Informierter Kauf |
5,533 |
$9.04 |
$50.02K |
77,018 |
| 2026-03-02 |
Michel Gerard J |
Chief Executive Officer |
Informierter Kauf |
11,200 |
$8.96 |
$100.31K |
342,034 |
| 2026-02-17 |
Michel Gerard J |
Chief Executive Officer |
RSU-Zuteilung |
97,500 |
- |
- |
97,500 |
| 2026-02-17 |
Vukovic Vojo |
Chief Medical Officer |
RSU-Zuteilung |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Pennell Sandra |
Chief Financial Officer |
RSU-Zuteilung |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Muir Kevin |
GM Interventional Oncology |
RSU-Zuteilung |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU-Zuteilung |
28,250 |
- |
- |
28,250 |
| 2026-02-17 |
Rook Martha S. |
Chief Operating Officer |
RSU-Zuteilung |
28,250 |
- |
- |
28,250 |
| 2025-11-21 |
Sylvester John Richard |
Director |
Informierter Kauf |
4,386 |
$8.89 |
$38.99K |
14,936 |
| 2025-11-11 |
Michel Gerard J |
Chief Executive Officer |
Informierter Kauf |
11,500 |
$8.53 |
$98.05K |
330,834 |
| 2025-06-12 |
Vukovic Vojo |
Chief Medical Officer |
Optionsausübung (Verkauf) |
42,000 |
$4.78 |
$200.76K |
58,500 |
| 2025-05-15 |
Czerepak Elizabeth |
Director |
RSU-Zuteilung |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Salamon Steven A J |
Director |
RSU-Zuteilung |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Martell Bridget A |
Director |
RSU-Zuteilung |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Sylvester John Richard |
Director |
RSU-Zuteilung |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-15 |
Aharon Gil |
Director |
RSU-Zuteilung |
22,500 |
$16.05 |
$361.13K |
22,500 |
| 2025-05-05 |
Rosalind Advisors, Inc. |
Director |
Optionsausübung (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-05-05 |
Salamon Steven A J |
Director |
Optionsausübung (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-05-05 |
Aharon Gil |
Director |
Optionsausübung (ITM) |
400,000 |
$10.00 |
$4M |
3,413,468 |
| 2025-02-07 |
Michel Gerard J |
Chief Executive Officer |
RSU-Zuteilung |
390,000 |
$16.25 |
$6.34M |
390,000 |
| 2025-02-07 |
Vukovic Vojo |
Chief Medical Officer |
RSU-Zuteilung |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Pennell Sandra |
Chief Financial Officer |
RSU-Zuteilung |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Muir Kevin |
GM Interventional Oncology |
RSU-Zuteilung |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU-Zuteilung |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2025-02-07 |
Rook Martha S. |
Chief Operating Officer |
RSU-Zuteilung |
113,000 |
$16.25 |
$1.84M |
113,000 |
| 2024-12-24 |
Rosalind Advisors, Inc. |
Director |
Optionsausübung |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-12-24 |
Aharon Gil |
Director |
Optionsausübung |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-12-24 |
Salamon Steven A J |
Director |
Optionsausübung |
603,954 |
$0.01 |
$6.04K |
1,323,919 |
| 2024-10-30 |
Rosalind Advisors, Inc. |
Director |
Option verfallen |
- |
- |
- |
- |
| 2024-10-30 |
Salamon Steven A J |
Director |
Option verfallen |
- |
- |
- |
- |
| 2024-10-30 |
Aharon Gil |
Director |
Option verfallen |
- |
- |
- |
- |
| 2024-10-22 |
Michel Gerard J |
Chief Executive Officer |
Optionsausübung (Verkauf) |
16,666 |
$6.00 |
$100K |
- |
| 2024-05-23 |
Stoll Roger G Phd |
Director |
Aktienrückgabe |
19,682 |
$7.25 |
$142.69K |
- |
| 2024-05-23 |
Czerepak Elizabeth |
Director |
RSU-Zuteilung |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Salamon Steven A J |
Director |
RSU-Zuteilung |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Martell Bridget A |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-05-23 |
Martell Bridget A |
Director |
RSU-Zuteilung |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Sylvester John Richard |
Director |
RSU-Zuteilung |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-05-23 |
Aharon Gil |
Director |
RSU-Zuteilung |
22,500 |
$7.85 |
$176.63K |
22,500 |
| 2024-04-18 |
Rosalind Advisors, Inc. |
Director |
Umwandlung (Kauf) |
991,615 |
- |
- |
2,763,468 |
| 2024-04-18 |
Rosalind Advisors, Inc. |
Director |
Optionsausübung (ITM) |
619,946 |
$0.01 |
$6.2K |
2,763,468 |
| 2024-04-18 |
Salamon Steven A J |
Director |
Optionsausübung (ITM) |
619,946 |
$6,199.46 |
$3.84B |
2,732,586 |
| 2024-04-18 |
Salamon Steven A J |
Director |
Optionsausübung (ITM) |
619,946 |
$0.01 |
$6.2K |
2,732,586 |
| 2024-04-18 |
Aharon Gil |
Director |
Umwandlung (Kauf) |
991,615 |
- |
- |
2,681,271 |
| 2024-04-18 |
Aharon Gil |
Director |
Optionsausübung (ITM) |
619,946 |
$0.01 |
$6.2K |
2,681,271 |
| 2024-03-19 |
Michel Gerard J |
Chief Executive Officer |
RSU-Zuteilung |
40,323 |
$3.72 |
$150K |
302,668 |
| 2024-03-19 |
Vukovic Vojo |
Chief Medical Officer |
RSU-Zuteilung |
26,882 |
$3.72 |
$100K |
126,882 |
| 2024-03-19 |
Pennell Sandra |
SVP of Finance, Pfo and Pao |
RSU-Zuteilung |
26,881 |
$3.72 |
$100K |
61,052 |
| 2024-03-19 |
Muir Kevin |
GM Interventional Oncology |
RSU-Zuteilung |
13,441 |
$3.72 |
$50K |
18,582 |
| 2024-03-19 |
Hoffman David L. |
Gen'l Counsel, Cco & Secy |
RSU-Zuteilung |
20,161 |
$3.72 |
$75K |
74,330 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
